Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin.

Bonnefont-Rousselot D, Benouda L, Bittar R, Darabi-Amin M, Demondion P, Lesnik P, Leprince P, Kontush A, Charniot JC, Giral P.

Nutr Metab Cardiovasc Dis. 2019 Aug 3. pii: S0939-4753(19)30290-X. doi: 10.1016/j.numecd.2019.07.022. [Epub ahead of print]

PMID:
31753791
2.

Non-linearity and gaps in results distribution over successive Roche Lipase method applications: improvement but persistence.

Robert de Rancher MA, Gobeaux-Chenevier C, Lemarechal H, Alkouri R, Borderie D, Bonnefont-Rousselot D, Monneret D.

Scand J Clin Lab Invest. 2019 Dec;79(8):572-578. doi: 10.1080/00365513.2019.1672087. Epub 2019 Sep 30.

PMID:
31566421
3.

Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial.

Mircher C, Sacco S, Bouis C, Gallard J, Pichot A, Le Galloudec E, Cieuta C, Marey I, Greiner-Mahler O, Dorison N, Gambarini A, Stora S, Durand S, Polak M, Baruchel A, Schlumberger E, Dewailly J, Azar-Kolakez A, Guéant-Rodriguez RM, Guéant JL, Borderie D, Bonnefont-Rousselot D, Blondiaux E, Ravel A, Sturtz FG.

Genet Med. 2019 Jul 8. doi: 10.1038/s41436-019-0597-8. [Epub ahead of print]

PMID:
31281181
4.

Outlier removal methods for skewed data: impact on age-specific high-sensitive cardiac troponin T 99th percentiles.

Monneret D, Gellerstedt M, Roche F, Bonnefont-Rousselot D.

Clin Chem Lab Med. 2019 Sep 25;57(10):e244-e247. doi: 10.1515/cclm-2018-1366. No abstract available.

PMID:
30860976
5.

Postprandial lipid absorption in seven heterozygous carriers of deleterious variants of MTTP in two abetalipoproteinemic families.

Di Filippo M, Varret M, Boehm V, Rabès JP, Ferkdadji L, Abramowitz L, Dumont S, Lenaerts C, Boileau C, Joly F, Schmitz J, Samson-Bouma ME, Bonnefont-Rousselot D.

J Clin Lipidol. 2019 Jan - Feb;13(1):201-212. doi: 10.1016/j.jacl.2018.10.003. Epub 2018 Oct 24.

PMID:
30522860
6.

Medical biology in the face of the evolution of health care needs.

Dreux C, Maquart FX, Bonnefont-Rousselot D, Delpech M, Gueant JL, Le Bouc Y, Massoubre B, Porquet D, Rives N, Vigneron C.

Ann Biol Clin (Paris). 2018 Oct 1;76(5):485-491. doi: 10.1684/abc.2018.1370. Review.

PMID:
30154066
7.

Estimated GFR-specific 99th percentiles for high-sensitive cardiac troponin T based on the adjusted analytical change limit (adjACL) in hospitalized patients.

Monneret D, Hausfater P, Riou B, Bonnefont-Rousselot D.

Clin Chem Lab Med. 2018 Dec 19;57(2):e5-e7. doi: 10.1515/cclm-2018-0485. No abstract available.

PMID:
30004901
8.

Use of Resveratrol Self-Emulsifying Systems in T/C28a2 Cell Line as Beneficial Effectors in Cellular Uptake and Protection Against Oxidative Stress-Mediated Death.

Le Clanche S, Cheminel T, Rannou F, Bonnefont-Rousselot D, Borderie D, Charrueau C.

Front Pharmacol. 2018 May 24;9:538. doi: 10.3389/fphar.2018.00538. eCollection 2018.

9.

Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels.

Monneret D, Mestari F, Djiavoudine S, Bachelot G, Cloison M, Imbert-Bismut F, Bernard M, Hausfater P, Lacorte JM, Bonnefont-Rousselot D.

Scand J Clin Lab Invest. 2018 Sep;78(5):346-351. doi: 10.1080/00365513.2018.1471618. Epub 2018 May 15.

PMID:
29764220
10.

Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.

Palich R, Tubiana R, Abdi B, Mestari F, Guiguet M, Imbert-Bismut F, Katlama C, Bonnefont-Rousselot D, Isnard-Bagnis C.

J Antimicrob Chemother. 2018 Jul 1;73(7):1935-1939. doi: 10.1093/jac/dky112.

PMID:
29688533
11.

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Peta V, Tse C, Perazzo H, Munteanu M, Ngo Y, Ngo A, Ramanujam N, Verglas L, Mallet M, Ratziu V, Thabut D, Rudler M, Thibault V, Schuppe-Koistinen I, Bonnefont-Rousselot D, Hainque B, Imbert-Bismut F, Merz M, Kullak-Ublick G, Andrade R, van Boemmel F, Schott E, Poynard T; Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière; Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium.

PLoS One. 2017 Dec 29;12(12):e0189436. doi: 10.1371/journal.pone.0189436. eCollection 2017.

12.

Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach.

Monneret D, Gellerstedt M, Bonnefont-Rousselot D.

Clin Chem Lab Med. 2018 Apr 25;56(5):685-696. doi: 10.1515/cclm-2017-0256.

PMID:
29176015
13.

Blood lipid tests in 2017.

Couderc R, Antar M, Bonnefont-Rousselot D, Paul JL, Therond P.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):646-652. doi: 10.1684/abc.2017.1303. Review.

14.

Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy.

Carillion A, Feldman S, Na N, Biais M, Carpentier W, Birenbaum A, Cagnard N, Loyer X, Bonnefont-Rousselot D, Hatem S, Riou B, Amour J.

PLoS One. 2017 Jul 20;12(7):e0180103. doi: 10.1371/journal.pone.0180103. eCollection 2017.

15.

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.

Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, Lacorte JM, Gastaldelli A, Schuppan D, Schattenberg JM, Hakkarainen A, Lundbom N, Jousilahti P, Männistö S, Keinänen-Kiukaanniemi S, Saltevo J, Anstee QM, Yki-Järvinen H.

Diabetologia. 2017 Oct;60(10):1873-1882. doi: 10.1007/s00125-017-4340-1. Epub 2017 Jun 29.

PMID:
28660493
16.

Effects of a Carbohydrate-, Glutamine-, and Antioxidant-Enriched Oral Nutrition Supplement on Major Surgery-Induced Insulin Resistance: A Randomized Pilot Study.

van Stijn MFM, Soeters MR, van Leeuwen PAM, Schreurs WH, Schoorl MG, Twisk JWR, De Bandt JP, Bonnefont-Rousselot D, Cynober L, Ackermans MT, Serlie MJ, Houdijk APJ.

JPEN J Parenter Enteral Nutr. 2018 May;42(4):719-729. doi: 10.1177/0148607117711691. Epub 2017 Dec 20.

PMID:
28541810
17.

Diaphragmatic function is enhanced in fatty and diabetic fatty rats.

De Jong A, Carreira S, Na N, Carillion A, Jiang C, Beuvin M, Lacorte JM, Bonnefont-Rousselot D, Riou B, Coirault C.

PLoS One. 2017 Mar 22;12(3):e0174043. doi: 10.1371/journal.pone.0174043. eCollection 2017.

18.

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.

Bruckert E, Kalmykova O, Bittar R, Carreau V, Béliard S, Saheb S, Rosenbaum D, Bonnefont-Rousselot D, Thomas D, Emery C, Khoshnood B, Carrié A.

Atherosclerosis. 2017 Feb;257:130-137. doi: 10.1016/j.atherosclerosis.2017.01.015. Epub 2017 Jan 16.

PMID:
28131047
19.

Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors.

Bittar R, Aslangul É, Giral P, Assoumou L, Valantin MA, Kalmykova O, Federspiel MC, Cherfils C, Costagliola D, Bonnefont-Rousselot D; ANRS 126 study group.

C R Biol. 2017 Feb;340(2):109-113. doi: 10.1016/j.crvi.2016.11.004. Epub 2016 Dec 20.

20.

Introducing High-Sensitivity Cardiac Troponin T as a Biomarker of OSA-Related Cardiovascular Morbidity in Obesity Hypoventilation Syndrome.

Monneret D, Giral P, Bonnefont-Rousselot D, Roche F.

Chest. 2016 Dec;150(6):1408-1409. doi: 10.1016/j.chest.2016.08.1467. No abstract available.

PMID:
27938750

Supplemental Content

Loading ...
Support Center